Physician profile
Robert Caruso
NPI 1588604557
$6,734.60
in general payments reported to CMS, 2019-2025
42 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $359 · 2021: $436 · 2022: $2,196 · 2023: $734 · 2024: $1,051 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,733 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,732.85 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,629.58 | 2021-2023 | Axonics, Bulkamid |
| Pfizer INC. | $688.03 | 2019-2025 | |
| Janssen Biotech, INC. | $546.69 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $538.02 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $473.63 | 2019-2025 | Provenge |
| Olympus America INC. | $282.68 | 2024-2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $275.89 | 2019-2025 | |
| Abbvie INC. | $184.72 | 2019-2024 | Botox |
| Boston Scientific Corporation | $180.37 | 2019-2024 | Upsylon |
| Progenics Pharmaceuticals, INC. | $176.63 | 2024-2025 | |
| Coloplast Corp | $151.55 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $134.10 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $129.82 | 2021-2023 | Prolaris |
| Myovant Sciences INC. | $128.60 | 2021-2022 | |
| Urogen Pharma, INC. | $121.31 | 2022-2024 | Jelmyto |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $114.74 | 2023-2025 | Illuccix |
| Merck Sharp & Dohme LLC | $99.49 | 2023-2025 | Keytruda, Lynparza |
| Agiliti Surgical, INC. | $83.69 | 2019-2024 | Koelis Trinity Fusion Biopsy System |
| Endo Pharmaceuticals INC. | $76.65 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $73.76 | 2019-2022 | |
| Tolmar, INC. | $70.01 | 2024-2025 | Eligard, Jatenzo |
| Teleflex LLC | $69.33 | 2022-2025 | Urolift |
| Ferring Pharmaceuticals INC. | $55.17 | 2024-2025 | Adstiladrin |
| Davol INC. | $54.86 | 2020 | |
| Endo USA, INC. | $51.07 | 2024 | Xiaflex, Aveed |
| Medtronic USA, INC. | $36.44 | 2019 | |
| Ethicon US, LLC | $34.27 | 2024 | Echelon; Endopath, Stratafix |
| Conmed Corporation | $27.84 | 2024 | Airseal |
| Hollister Incorporated | $22.29 | 2023 | Vapro Pocket |
| Mimedx Group, INC. | $22.01 | 2025 | |
| Novartis Pharmaceuticals Corporation | $21.09 | 2025 | |
| Palette Life Sciences, INC. | $20.46 | 2022 | |
| Calyxo, INC. | $18.98 | 2025 | Cvac Aspiration System |
| Travere Therapeutics, INC. | $18.74 | 2020 | |
| Vanda Pharmaceuticals INC. | $18.62 | 2025 | Fanapt |
| Royal Biologics, INC. | $17.80 | 2020 | |
| Escala Medical INC. | $16.00 | 2025 | |
| Laborie Medical Technologies Corp. | $15.44 | 2020 | |
| Acerus Pharmaceuticals Corporation | $15.00 | 2022 | |
| Blue Earth Diagnostics | $14.48 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.81 | 2022 | |
| Allergan, INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Caruso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.